scutellarin has been researched along with enalapril in 1 studies
| Studies (scutellarin) | Trials (scutellarin) | Recent Studies (post-2010) (scutellarin) | Studies (enalapril) | Trials (enalapril) | Recent Studies (post-2010) (enalapril) |
|---|---|---|---|---|---|
| 441 | 7 | 309 | 6,311 | 1,924 | 859 |
| Protein | Taxonomy | scutellarin (IC50) | enalapril (IC50) |
|---|---|---|---|
| Angiotensin-converting enzyme | Homo sapiens (human) | 0.3536 | |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 2.7083 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 1.2 | |
| Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.14 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.14 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qi, XM; Shen, JJ; Wu, YG; Xu, XX; Zhang, P; Zhang, W | 1 |
1 other study(ies) available for scutellarin and enalapril
| Article | Year |
|---|---|
Superior renoprotective effects of the combination of breviscapine with enalapril and its mechanism in diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Flavonoids; Kidney; Male; Phytotherapy; Random Allocation; Rats; Rats, Wistar; Transforming Growth Factor beta1 | 2013 |